非小細胞肺がん患者の治療に使用されるブリガチニブに関する調査

基本情報

NCT ID

NCT05100069

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

500

治験依頼者名

Takeda

概要

This study is a survey in Japan of Brigatinib tablets used to treat Japanese people with non-small cell lung cancer. The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study. The main aim of the study is to check for side effects related to lung disease from Brigatinib. During the study, participants with non-small cell lung cancer will take Brigatinib tablets according to their clinic's standard practice. The study doctors will check for side effects from Brigatinib for 1 year.

対象疾患

介入

依頼者（Sponsor）